RxDoctor Payments Data

Stephannie Rey-Cubero, APRN

Family · Orlando, FLNPI 1285201822

Payments from drug & device makers

$491in general payments, 2019–2025

Across 19 payments — averaging $25.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$226
  • AbbVie$53
  • Amgen$46
  • UCB, Inc.$33
  • Bayer$32
  • AstraZeneca$28
  • plus $73 from 4 others

What the payments were for

  • Food & beverage$39280%
  • Education$9920%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$491 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$14,217
Medicare patients
74
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide20$32,048
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$27,821
EliquisApixaban21$23,167
JardianceEmpagliflozin14$23,006
TrulicityDulaglutide14$19,898
SymbicortBudesonide/Formoterol Fumarate34$12,485
Spiriva RespimatTiotropium Bromide12$7,410
JanumetSitagliptin Phos/Metformin Hcl12$6,424
LantusInsulin Glargine,hum.Rec.Anlog17$2,864
Albuterol Sulfate HfaAlbuterol Sulfate46$1,441
Azelastine Hcl24$1,177
Atorvastatin Calcium145$1,118
Levothyroxine Sodium98$1,015
Gabapentin57$951
Rosuvastatin Calcium96$876

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$21$23,16721 claims
Lilly USA, LLCTrulicity$18$19,89814 claims
AstraZenecaSymbicort$28$12,48534 claims
AbbVieSynthroid$53$62412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 14,618 family providers in Florida.

Other family in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →